Bendamustine and Melphalan in Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Multiple Myeloma Patient Registry
- Status
- TERMINATED
- Phase
- N/A
Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE4
2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide
- Status
- TERMINATED
- Phase
- PHASE3
Diagnostic Imaging of Myeloma Bone Lesions
- Status
- COMPLETED
- Phase
- NA
Prevalence of Asymptomatic Thrombosis in Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- NA
Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- Status
- RECRUITING
- Phase
- N/A
Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Expanded Access to Venetoclax
- Status
- AVAILABLE
- Phase
- N/A
cGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.
- Status
- UNKNOWN
- Phase
- N/A
Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study)
- Status
- COMPLETED
- Phase
- NA
Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide
- Status
- TERMINATED
- Phase
- PHASE2
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- Status
- RECRUITING
- Phase
- PHASE1
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3